lamivudine has been researched along with Nasopharyngeal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, SL; Jacobson, IV; Milross, CG; Post, JJ; Varma, R | 1 |
| Chan, AT; Chan, PK; Ho, WM; Hui, EP; Johnson, PJ; Lam, KC; Lee, JJ; Mo, FK; Mok, TS; Yeo, W | 1 |
1 trial(s) available for lamivudine and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carrier State; Cisplatin; Female; Hepatitis B; Hepatitis B virus; Humans; Incidence; Lamivudine; Male; Middle Aged; Nasopharyngeal Neoplasms; Radiotherapy, Adjuvant; Virus Activation | 2005 |
1 other study(ies) available for lamivudine and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
Combination antiretroviral therapy as treatment for human immunodeficiency virus-associated mucosa-associated lymphoid tissue type lymphoma of the nasopharynx.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Humans; Lamivudine; Lopinavir; Lymphoma, AIDS-Related; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Nasopharyngeal Neoplasms; Pyrimidinones; Radiotherapy, Adjuvant; Remission Induction; Ritonavir; Viral Load; Zidovudine | 2011 |